August 2008

Pfizer Defends Claims Against Parkinson’s Disease Drug in Bellwether MDL

North America - United States | North America | United States - Minnesota

In its first and only bellwether MDL trial, Pfizer defended claims made by plaintiffs that they failed to warn of the side effects of their drug for Parkinson’s disease. Faegre Baker Daniels served as MDL liaison, co-trial and local counsel in Minnesota for the trial. Charbonneau v. Pfizer, Inc. et. al, No. 06-CV-1215, U.S. District Court, District of Minnesota.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.